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ThromboembolismUnlike the English National Joint Registry (NJR) for arthroplasty, no surgeon driven national database
currently exists for ligament surgery in England. Therefore information on outcome and adverse events
following anterior cruciate ligament (ACL) surgery is limited to case series. This restricts the ability to make
formal recommendations upon surgical care. Prospectively collected data, which is routinely collected on
every NHS patient admitted to hospital in England, was analysed to determine national rates of 90-day
symptomatic deep venous thrombosis (DVT), pulmonary thromboembolism (PTE) rate, 30-day wound
infection and readmission rates following primary ACL reconstruction between March 2008 and February
2010 (13,941 operations, annual incidence 13.5 per 100,000 English population). 90-day DVT and PTE rates
were 0.30% (42) and 0.18% (25) respectively. There were no in-hospital deaths. 0.75% (104) of the consecutive
patient cohort had a wound complication recorded. 0.25% (35) underwent a further procedure to wash out
the infected knee joint and 1.36% (190) were readmitted to an orthopaedic ward within 30 days. This is the
first national comprehensive study of the incidence of significant complications following ACL surgery in
England. This should allowmeaningful interpretation of future baseline data supporting the development of a
national ligament registry.-Cleveland, TS8 9XP, UK. Tel.:
Jameson).
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Annually, around100,000primary anterior cruciate ligament (ACL)
reconstructions are performed in the US, with this number increasing
[1]. Accurate figures for the frequency of such procedures in English
practice do not exist, and there remains little information on the
epidemiology of post-operative complications. There is a growing
awareness of venous thromboembolism (VTE) following orthopaedic
surgery, and there are formal recommendations on thromboprophy-
laxis from the National Institute for Health and Clinical Effectiveness
(NICE) following lower limb arthroplasty [2] but no reliable data exists
to allow for informed discussion regarding thrombotic risks following
modern endoscopic ligament surgery. Indeed a publication entitled
‘Complications of arthroscopic reconstruction of the anterior cruciate
ligament’ specifically failed to discuss rates of VTE or infection post
surgery [3]. The reader may therefore draw the conclusion that
thrombotic events or infections following arthroscopic ACL surgery do
not represent a clinical problem.
ACL reconstruction performed as a day case (less than 24 h stay) is
increasingly being reported in associationwith accelerated rehabilitation[4]. Despite this, there have been sporadic reports of VTE complications
ranging from documented deep vein thrombosis (DVT) through to fatal
pulmonary thromboembolus (PTE) [5]. BASK best practice guidelines
state that thromboprophylaxis is unnecessary given the rarity of VTE [6].
This is in no small measure due to the lack of a prospective national
database or large series analyses. Our knowledge is confined to individual
surgeon case series and highly subjective postal surveys with poor
uptake. It is essential for the purposes of making appropriate and
informed recommendations on the prevention of complications follow-
ing ligament surgery that knowledge of relative risk should exist.
Moreover, national standard setting, comparison between units, and
evidence for future consultant surgeon revalidation are only possible
with population-based datasets.
In depth data concerning diagnosis, operation, co-morbidities and
post-operative complications is prospectively collected on every NHS
patient admitted to hospitals in England (Hospital episode statistics
data [HES]) [7]. The risk of VTE following foot/ankle surgery has
previously been analysed [8]. From this independent English database
we have now analysed data for ACL surgery.
2. Methods
Data for English NHS patients (treated in NHS, private or
independent sector treatment hospitals) who underwent planned
ACL reconstruction between March 2008 and February 2010 were
Table 1
Demographics of patients undergoing anterior cruciate ligament reconstruction in the
English NHS (2008–2010).
ACL reconstruction (N=13,941)
Age (years, mean and range) 29.34 (8–83)
Charlson score
0 13012 (93.3%)
≥1 929 (6.7%)
Sex
Female 2854 (20.5%)
Male 11084 (79.5%)
Missing data 3 (0.0%)
Co-morbidities
IDDM 25 (0.2%)
NIDDM 38 (0.3%)
RA 5 (0.0%)
Length of stay
b1 day 2681 (19.2%)
b2 days 11103 (79.6%)
Providers (241 units)
Minimal volume (62 units) 127 (0.9%)
Low volume (79 units) 2096 (15.0%)
Mid volume (88 units) 8469 (60.7%)
High volume (12 units) 3249 (23.3%)
ACL— anterior cruciate ligament, IDDM— Insulin dependent diabetes mellitus, NIDDM—
non-insulin dependent diabetes mellitus, RA — rheumatoid arthritis, Minimal volume —
b3 ACLs per year, Low volume—≥3b25ACLs per year,Mid volume—≥25b100 ACLs per
year, High volume — ≥100 ACLs per year
Fig. 1. Age distribution of patients undergoing anterior cruciate ligament reconstruction
in the English NHS (2008–2010).
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data). This was augmented with more recent data from the Secondary
Users Service (a system that reports and analyses the latest data from
NHS units to support planning and commissioning of healthcare
provision) [9]. HES covers all admissions to English hospitals
providing care for NHS patients and includes fifteen diagnosis fields
(coded using the International Statistical Classification of Diseases and
Related Health Problems [10th revision], ICD-10 codes), and fifteen
surgical procedure fields (coded using Office of Population, Censuses
and Surveys Classification of Surgical Operations and Procedures [4th
revision], OPCS-4 codes). Within the system, patients are identified by
a pseudonymisation identifier created by the Information Centre for
Health and Social Care (ICHSC), in order that independent data
analysis providers have no access to patient identifiable information
[10]. Records belonging to the same patient (defined using a
combination of date of birth, sex and postcode) were linked and the
number of days between the index operation and any subsequent
orthopaedic re-admission to any NHS hospital was collected. Patients
with missing dates of operation were excluded. By employing the
appropriate ICD-10 or OPCS codes, complication rates were identified.
Rates of PTE, symptomatic DVT and all-cause in-hospital mortality
within 90 days were established, even if successfully discharged
following the primary procedure. Length of stay and readmission
within 30 days of the primary procedure were also analysed. Wound
infections and haematomas were grouped as ‘wound complications’.
In addition, deep wound infection (defined as those who returned to
theatre for joint washout) were also analysed independently. Age, sex
and Charlson score [11] were recorded for each patient. The Charlson
co-morbidity index predicts the one-year mortality for a patient who
may have a range of co-morbid conditions. Each condition is assigned
with a score of 1, 2, 3 or 6 (Appendix 1) depending on the risk of dying
associated with this condition. The combined total score is then used
to predict patient-specific overall mortality.
CHKS has approval to re-use HES data with the permission of The
Health and Social Care Information Centre [12]. Codes are summarised
in Appendix 2. Information about the mechanism of injury, the
duration of symptoms, severity of damage and the method of
reconstruction was not available, due to the nature of this database.
Provider identification numbers, recorded in the HES database, were
used to calculate units' yearly volume of ACL reconstructions. Surgical
volumewas categorised as high (N100 cases per year),mid (25–100) or
low (N3b25). In addition, funnel plots (produced in MATLAB) were
used to compare individual units with the national baseline (mean) for
the adverse outcomes (VTE, re-operation, infection and readmission).
These plots are recommended as a graphical aid for institutional
comparisons in order to compare proportions and assess association
between outcome and volume of cases [13]. Control limits create a
funnel around the baseline (mean hospital performance) in order to
identify statistical outliers. The score confidence interval as described by
Wilson was used to create limits [14]. This prevents spurious ranking of
institutions into ‘league tables.’ For each adverse outcome scatter plots
of performance, as a percentage, were generated against the number of
cases reported (the denominator for the percentage). ‘Population’
represents the number of ACLs performed during the study period (two
years) in the plots. In this analysis there was no risk adjustment. Units
performing less than three per year were excluded from the funnel plot
to avoid unnecessary low volume clutter.
Odds ratios (OR) and 95% confidence intervals [15] were calculated
for rates of post-operative complications using the conditions ‘age’
(categorised as less than twenty, twenty to 30, 30 to 40, or 40 and
over), ‘sex’, ‘Charlson score and co-morbidities’, ‘length of stay’
(less than one day, one-two days, more than two days) and ‘hospital
provider volume’ (low, mid and high volume). For each condition, one
category was used as a reference compared to which all other
categories were compared. Complications tested were VTE within
90 days, any wound complication within 30 days, re-operation fordeep wound infection within 30 days, and orthopaedic readmission
within 30 days. The null hypothesis (OR=1)was tested using the chi-
square test (alpha=0.05) for a 2×2 contingency table (Table 3).
3. Results
Table 1 outlines the patient demographics. A total of 13941 ACL reconstructions
were performed in the English NHS in the 24-month study period between 2008 and
2010. Data was recorded at 241 units of which 179 performedmore than three ACLs per
year (accounting for 99.1% of patients). Mean age was 29.3 years with a range of 8–83.
Fig. 1 displays the spread of cases by age. The majority of patients were fifteen to
45 years of age. Three patients (0.0%) under 10 years old and 47 (0.3%) over 65 years
underwent ACL reconstruction.
The spread of inpatient stay is shown in Fig. 2. The majority of patients (79.6%)
stayed in hospital for less than two days, although the true day case figure is
considerably lower at around 20%. 99% of patients were discharged within four days.
Table 2 summarises the complications identified during the study period as a
percentage of the total group. Within 90 days of ACL reconstruction, there were 67
thrombotic (peripheral and central, non fatal PTE) events in 62 patients. There were no
deaths recorded.
It can be seen from Fig. 3 that ACL surgery increases the risk of VTE comparedwith a
control group of non-surgical patients, but remains at approximately 25% of lower limb
arthroplasty rates. When data was analysed for each unit to create funnel plots, no
Fig. 2. Length of stay recorded for ACL reconstruction patients in the English NHS
(2008–2010).
Table 2
National complication rates following anterior cruciate ligament reconstruction in the
English NHS (2008–2010).
Complication Number of patients (%)
Any wound complication within 30 days 104 (0.75)
RTT for deep infection 35 (0.25)
Orthopaedic readmission within 30 days 190 (1.36)
Readmission with wound complications 82 (0.59)
VTE event within 90 days⁎ 62 (0.44)
DVT 42 (0.30)
PTE 25 (0.18)
Death within 90 days 0
ACL — anterior cruciate ligament, RTT — return to theatre, VTE — venous
thromboembolism.
⁎ 5 patients had both DVT and PTE, DVT — deep vein thrombosis, PTE — pulmonary
thromboembolism.
Fig. 4. Funnel plot of 30-day return to theatre for infection following ACL reconstruction
in units providing care for English NHS patients.
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wound complication within 30 days, 35 (0.25%) required a further operation to wash
out the infected knee joint. Figs. 4 and 5 display this data in funnel plots for each unit.
There are no outlying units for reoperation for infection. However, there is one high
volume unit that falls on the 95% confidence limits for wound complications.
Fig. 6 shows one outlier (bold square) for 30-day readmission, with several others
close to the 95% confidence line. One hundred ninety patients (1.36%)were readmitted to
orthopaedics within 30 days of discharge. Of these, just under half had a wound
complication recorded.
Table 3 shows that the risk of a VTE event was significantly higher in patients
40 years old and over (odds ratio (OR) 2.36, 95% confidence intervals (CI) 1.29–4.34,
p=0.004), although length of stay and existing co-morbidities did not appear to have
an influence. Male sex was a predictor of 30-day readmission (OR=1.96 (95% CI 1.26–Fig. 3. 90-day VTE rate following ACL reconstruction compared with lower limb
arthroplasty and background risk. VTE — venous thromboembolism, ACL — anterior
cruciate ligament reconstruction, Background risk in middle-aged, female, non-surgical
population [17], TKR- total knee replacement, THR — total hip replacement. VTE risk
after THR and TKR [18].3.06), inverted from the value in Table 3, showing the OR for females, p=0.002). There
were no predictors for 30-day wound complication or reoperation for infection.
4. Discussion
Anterior cruciate ligament reconstruction is considered a safe
procedure performed endoscopically with low complication rates. The
literature describes revision rates for graft failure and poor tunnel
position but little information on infection and VTE [3]. To the best of
our knowledge this is the first independent comprehensive report
from an English population database for ACL reconstruction. Over the
last 2 years (2008–2010), 13,941 primary ACL reconstructions were
performed (annual incidence 13.5 per 100,000 English population).
The majority of these patients were discharged within two days of
surgery. It is a common perception that ACL surgery is a ‘day case’. InFig. 5. Funnel plot of 30-daywound complications following ACL reconstruction in units
providing care for English NHS patients.
Fig. 6. Funnel plot of 30-day readmission following ACL reconstruction in units
providing care for English NHS patients.
Fig. 7. Funnel plot of 90-day VTE event following ACL reconstruction in units providing
care for English NHS patients.
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procedures in the English NHS.
Rates of wound complications, early re-operation for infection and
readmission were low and there were no deaths recorded. Infection is
a rare complication after ACL reconstruction and ranges from 0.3% to
1.7%, usually involving bacterial organisms [16]. This can range from
superficial surgical site infection and minor wound complications to
septic arthritis of the knee with devastating consequences. Lyman
et al. [1] looked at complications post surgery and quoted a
readmission rate within 90 days of 2.3%. Our 30-day readmission
rate was 1.4%. However, there appeared to be more variance from the
baseline in this data compared with other complications, with several
units in the funnel plots straying towards the upper 95% confidence
limits. This data may be important in the future as English NHS Trusts
are penalised for every readmission following elective surgery [17].
Our low infection rate combined with low return to theatre figuresTable 3
Predictors of outcomes.
90-day VTE 30-day wound complicatio
OR (95% CI) P value OR (95% CI) P valu
Age
b20 0 – 0.57
(0.24, 1.35)
0.195
20–30 Reference Reference
30–40 1.55
(0.84, 2.85)
0.152 1.12
(0.64, 1.94)
0.688
N40 2.36
(1.29,4.34)
0.004 1.22
(0.66, 2.25)
0.533
Charlson score
0 Reference Reference Reference Refere
≥1 0.97
(0.35, 2.66)
0.947 0 –
Sex
Female 1.47
(0.84, 2.57)
0.175 0.54
(0.27, 1.08)
0.076
Male Reference Reference
LOS
b1 day 0.82
(0.42, 1.60)
0.563 0.66
(0.32, 1.35)
0.248
N1b2 days Reference Reference
N2 days 0.63
(0.31, 1.31)
0.213 1.52
(0.91, 2.55)
0.107
Provider volume
Low 0.72
(0.29, 1.77)
0.477 0.97
(0.44, 2.14)
0.937
Mid Reference Reference
High 1.02
(0.56, 1.85)
0.939 1.15
(0.65, 2.03)
0.625
VTE— venous thromboembolism, OR— odds ratio, CI— confidence intervals, P value compar
NIDDM — non-insulin dependent diabetes mellitus, RA — rheumatoid arthritis, Low volume
ACLs per year.reassures and confirms that ACL reconstruction is a clean procedure.
Unfortunately, other than infections, we lack data on cause of
readmissions. This could suggest that we are underestimating
wound complication rates, or simply that patients are presenting
other complications that our analysis is unable to capture. Lyman et al.
[1] also found that low volume units had significantly higher
readmission rates. We found no such association with any of the
complications investigated in this study.
There is a commonly held view that ACL surgery is not associated
with VTE. This study has demonstrated that patients undergoing ACL
reconstruction are at greater risk of VTE when compared with a non-
surgical population, but much lower than lower limb arthroplasty
patients, and there were no fatal PTEs. Based on a middle-aged, female,
non-surgical population, the general background risk of aVTE eventwas
calculated as 0.058 per 1000 person months by Sweetland and
colleagues [18]. For a 90-day (3 month) period this is the equivalent
of 0.017% risk. VTE rates are therefore 26 times higher than the
background risk (0.44%) after ACL reconstruction. Jameson et al. [19]
have previously shown that VTE risk (excluding out of hospital fatal
PE rate) following lower limb arthroplasty is around 2%, similar to the
findings of Sweetland et al, and around 120 times higher than
background risk (Fig. 3). It should be noted that over 95% of lower
limb arthroplasty patients receive chemical thromboprophylaxis [20].
This data is unknown for ACL surgery, but is likely to be much lower.
Current guidelines from the statement of best practice in primary
ACL reconstruction for an isolated rupture, approved by the British
Orthopaedic Association, British Association for the Surgery of the
Knee and British Orthopaedic Sports Trauma Association state that the
risk of DVT following ACL surgery is very low and routine prophylaxis
is not indicated [6]. NICE does not currently make any specific
recommendations on thromboprophylaxis following ACL surgery,
although there is guidance on lower limb elective surgery. This states
that patients who undergo lower limb surgery lasting for more thann 30-day reoperation
for infection
30-day readmission
e OR (95% CI) P value OR (95% CI) P value
1.01
(0.32, 3.13)
0.989 1.16
(0.75, 1.78)
0.509
Reference Reference
1.71
(0.77, 3.80)
0.185 1.21
(0.85, 1.73)
0.277
1.51
(0.60, 3.85
0.381 1.06
(0.69, 1.61)
0.794
nce Reference Reference Reference Reference
0 – 0.94
(0.52, 1.70)
0.846
0.50
(0.17, 1.42)
0.184 0.50
(0.32, 079)
0.002
Reference Reference
0.78
(0.29, 2.09)
0.628 0.98
(0.67, 1.44)
0.923
Reference Reference
1.49
(0.69, 3.18)
0.305 1.14
(0.80, 1.63)
0.464
0.52
(0.14, 1.91)
0.313 1.43
(0.90, 2.29)
0.132
Reference Reference
0.98
(0.45, 2.12)
0.959 1.23
(0.85, 1.78)
0.280
ing group of interest with reference group, IDDM— Insulin dependent diabetes mellitus,
— ≥3b25 ACLs per year, Mid volume — ≥25b100 ACLs per year, High volume — ≥100
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from thromboembolic prophylaxis and should be offered both
chemically and mechanically, although this lacks an evidence base
(NICE 2010) [2]. However, there remains limited information on the
incidence/risk factors for VTE following ACL surgery. Despite a
thorough review of the literature we have found few reports from
small case series of the incidence and outcome following symptomatic
venous thrombosis after primary ACL surgery [5,21]. Other studies
identified risk factors for VTE as being over 40 years of age and an
operative duration greater than one hour [22]. Carlson et al. [23]
reviewed 3200 cases with only seven reported PTEs, and found that
53% of America Orthopaedic Society for Sports Medicine members
used some form of VTE prophylaxis. In this analysis, age over 40 years
was the only significant predictor of an increase in VTE risk, but there
were no fatal in-hospital PTEs in any group. Statistical testing failed to
identify an effect of any other variable on the complications analysed
(other than sex on readmission, which is difficult to explain).
However, it must be stressed that these adverse events are rare and
the statistics in this situation have not been particularly helpful in
stratifying risk.
The current knowledge of modern day ligament practice and
outcome in England is based upon low uptake postal surveys [4,24].
There are limited, small case series [25–27] outlining case mix,
outcome andmajor complications but there are significant drawbacks
to such methods of data collection, such as poor response rates, non-
validated questionnaires and a potential bias which can limit any
conclusions that may be drawn [28]. They may also lack accurate
representation of current practice [24]. In addition to these problems,
outcome data derived from small number case series is difficult to
interpret, as case selection does not accurately represent the normal
burden of clinical practice, and there has been focus placed on surgical
technique, timing of surgery and graft choice rather than outcome
[25–27].
The most comprehensive data to date is derived from the national
databases of Scandinavia. Established in June 2004, theNorwegianfirst
two years recorded 2714 primary ACL reconstructions. Of these, 77%
received prophylactic anticoagulation and 5% encountered periopera-
tive complications, ‘most often due to graft failure’ [29]. Interestingly
the use of thromboprophylaxis ranged from 17% in Denmark to 78% in
Norway but no information on type, duration, or dosage was available
[30]. Results from thefirst two years from theDanish registry looked at
4972 primary ACL reconstructions and quoted a perioperative
complication rate of 4.3% [31]. Despite commenting on the use of
thromboprophylaxis, there are no published VTE rates in any of the
registries, nor was there data available on readmission rates or return
to theatre for reoperation. Although these registries provide some
insight into potential trends, there is limited information on
breakdown of complications.
We accept that there are limitations within this observational
study.We have no data on type or duration of the thromboprophylaxis
regime. Nor were we able to comment on reasons for readmission
other than infection. In addition, the data collection and coding of
patients who are diagnosed with DVT as an outpatient may not be
entirely accurate, and the figures presented here may in fact be an
underestimate of the true 90-day DVT rate. Patients who die at home
would not be detected in this analysis, but those who become unwell
and subsequently die in hospital after readmission would be included.
We acknowledgeHES inaccuracies from the past [32], but the system is
constantly improving and remains the most accurate means of large
scale surgical data collection in England currently.
5. Conclusions
This studyhasquantified the complication rates forVTE, readmission
and infection following ACL surgery from a national database. Infection
rates are low with only one outlier for a 30-day reoperation.Readmission rates vary considerably, with several units having higher
than expected rates. Contrary to popular belief there is a real but small
risk of VTE following ACL surgery. Whether this justifies thrombopro-
phylaxis remains unanswered, given the lack of any real evidence in the
literature for benefit.We believe this data strengthens the argument for
a funded prospective ligament registry in the UK.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.knee.2010.11.011.
Acknowledgements
Tony Roberts, Clinical Effectiveness Specialist Advisor, South Tees
Hospital NHS Foundation Trust, for advice regarding the use of funnel
plots
References
[1] Lyman S, Koulouvaris P, Sherman S, Do H, Mandl LA, Marx RG. Epidemiology of
anterior cruciate ligament reconstruction. J Bone Joint Surg Am 2009;91:2321–8.
[2] National Institute forHealth andClinical Excellence. CG92Venous thromboembolism -
reducing the risk: full guideline. http://www.nice.org.uk/nicemedia/
live/12695/47920/47920.pdf January 2010 (Section 5.9, p126 and Section 13, p269).
Last accessed 27/10/2010.
[3] Allum R. Aspects of current management. Complications of arthroscopic
reconstruction of the anterior cruciate ligament. J Bone Joint Surg Br 2003;85B:
12–6.
[4] Kapoor B, Clement DJ, Kirkley A, Maffulli N. Current practice in the management of
anterior cruciate ligament injuries in the United Kingdom. Br J Sports Med
2004;38:542–4.
[5] Janssen RPA, Sala HA. Fatal pulmonary embolism after anterior cruciate ligament
reconstruction. Am J Sports Med 2007;35(6):1000–2.
[6] Best practice for primary anterior cruciate ligament reconstruction. NHS Evidence-
musculoskeletal. http://www.library.nhs.uk/musculoskeletal/viewResource.
aspx?resID=61272 Last accessed 04/11/2010.
[7] The Information Centre. HES online. Last assessed 01/11/2010.
[8] Jameson SS, Augustine A, James P, Townshend D, Reed MR. Major complications
following foot and ankle surgery – analysis using national hospital episode
statistics. J Bone Joint Surg Proceedings in press.
[9] Connecting for Health. http://www.connectingforhealth.nhs.uk/systemsandservices/
sus Last assessed 24/10/2010.
[10] Connecting for Health. Pseudonymisation implementation policy. www.connecting-
forhealth.nhs.uk/systemsandservices/sus/delivery/pseudo Last accessed
04/11/2010.
[11] Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying
prognostic comorbidity in longitudinal studies: development and validation. J
Chron Dis 1987;40(5):373–83.
[12] Copyright (c) 2010. Re-used with permission of the Health and Social Care
Information Centre. All rights reserved.
[13] Spiegelhalter DJ. Funnel plots for comparing institutional performance. Stat Med
2005;24:1185–202.
[14] Wilson EB. Probable inference, the law of succession, and statistical inference. J
Amer Statist Assoc 1927;22:209–12.
[15] Bland JM, Altman DG. The odds ratio. BMJ 2000;320:1468.
[16] Muscolo DL, Carbo L, Aponte-Tinao LA, Ayerza MA, Makino A. Massive bone loss
from fungal infection after anterior cruciate ligament arthroscopic reconstruction.
Clin Orthop Relat Res 2009;467(9):2420–5.
[17] Kmietowicz Z. Hospitals will be fined for emergency readmissions, says Lansley.
BMJ 2010;340:c3079.
[18] Sweetland S, Green J, Liu B, Berrington de González A, Canonico M, Reeves G, et al.
Duration and magnitude of the postoperative risk of venous thromboembolism in
middle aged women: prospective cohort study. BMJ 2009;339:b4583–91.
[19] Jameson SS, Bottle A, Malviya, Muller SD, Reed MR. The impact of national
guidelines for the prophylaxis of venous thromboembolism on the complications
of arthroplasty of the lower limb. J Bone Joint Surg Br 2010;92(1):123–9.
[20] National Joint Registry. 5th Annual Report. http://www.njrcentre.org.uk/NjrCen-
tre/LinkClick.aspx?fileticket=Da4%2b2sUVa%2fI%3d&tabid=86&mid=523 Last
accessed 23/10/2010.
[21] Cullison TR,MuldoonMP, Gorman JD, GoffWB. The incidence of deep vein thrombosis
in anterior cruciate ligament reconstruction. Arthroscopy 1996;12(6):657–9.
[22] Sherman OH, Fox JM, Snyder SJ, Del Pizzo W, Friedman MJ, Ferkel RD, et al.
Arthroscopy—“no problem surgery”. J Bone Joint Surg Am 1986;68:256–65.
[23] Carlson E, Steiner M, Brown C. Thromboembolic disease following arthroscopic
anterior cruciate ligament surgery. Presented at the annual meeting of the
American Orthopaedic Society of Sports medicine, Sun Valley, ID; 1993. July.
[24] Patel N, Chandratreya A, Radcliffe G, Bollen S. Current ACL practices in the UK: a
postal survey of BASK members. J Bone Joint Surg Br 2008;90-B(SUPP_III):583.
[25] Deehan DJ, Salmon LJ, Webb VJ, Davies A, Pinczewski LA. Endoscopic reconstruction
of the anterior cruciate ligament with an ipsilateral patellar tendon autograft. J Bone
Joint Surg Br 2000;82(7):984–91.
[26] Pinczewski LA, Lyman J, Salmon LJ, Russell VJ, Roe J, Linklater J. A 10-year
comparison of anterior cruciate ligament reconstructions with hamstring tendon
19S.S. Jameson et al. / The Knee 19 (2012) 14–19and patellar tendon autograft: a controlled, prospective trial. Am J Sports Med
2007;35(4):564–74 Epub 2007 Jan 29.
[27] Webb JM, Corry IS, Clingeleffer AJ, Pinczewski LA. Endoscopic reconstruction for
isolated anterior cruciate ligament rupture. J Bone Joint Surg Br 1998;80(2):
288–94.
[28] Edwards P. Questionnaires in clinical trials: guidelines for optimal design and
administration. Trials 2010;11:2.
[29] Granan LP, Bahr R, Steindal K, Furnes O, Engebretsen L. Development of a national
cruciate ligament surgery registry: The Norwegian National Knee Ligament
Registry. Am J Sports Med 2008;36(2):308–15.[30] Granan LP, Forssblad M, Lind M, Engebretsen L. The Scandinavian ACL registries
2004–2007: baseline epidemiology. Acta Orthop 2009;80(5):563–7.
[31] Lind M, Menhert F, Pedersen A. The first results from the Danish ACL
reconstruction registry: epidemiologic and 2 year follow-up results from 5, 818
knee ligament reconstructions. Knee Surg Sports Traumatol Arthrosc 2009;17:
117–24.
[32] Westaby S, Archer N, Manning N, Adwani S, Grebenik C, Ormerod O, Pillai R,
Wilson N. Comparison of hospital episode statistics and central cardiac audit
database in public reporting of congenital heart surgery mortality. BMJ 2007;335
(7623):759.
